Q

Qiagen NV
D

QGEN

49.355
USD
0.41
(0.83%)
مغلق
حجم التداول
40,309
الربح لكل سهم
2
العائد الربحي
0.51
P/E
29
حجم السوق
10,701,855,346
أصول ذات صلة
NEOUSD
NEOUSD
0.08038
(1.27%)
6.38111 USD
BDX
BDX
0.920
(0.47%)
195.920 USD
C
CRL
0.790
(0.51%)
156.560 USD
DGX
DGX
1.360
(0.76%)
179.800 USD
GILD
GILD
-0.680
(-0.57%)
118.320 USD
HOLX
HOLX
-0.225
(-0.33%)
67.840 USD
IQV
IQV
1.640
(0.87%)
191.080 USD
LH
LH
-0.95
(-0.35%)
270.37 USD
N
NEO
0.02000
(0.32%)
6.20500 USD
TMO
TMO
4.05
(0.83%)
489.18 USD
المزيد
الأخبار المقالات

العنوان: Qiagen N.V.

القطاع: Healthcare
الصناعة: Diagnostics & Research
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).